drugset / Trial / NCT00864396
Twice Daily Prevacid for the Treatment of Laryngopharyngeal Reflux
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether treatment with twice-daily Lansoprazole 30mg (Prevacid 30mg) and behavioral modifications for reflux is superior to treatment with behavioral modifications for reflux alone in the treatment of laryngopharyngeal reflux (LPR).
Timeline
- Start
- 2005-07
- Primary completion
- 2008-05
- Completion
- 2008-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lansoprazole | Other / unclassified | 30 mg | — |